The move marks the start-up of a new medical base in Taicang Port, focused on diagnostic reagents for early cancer detection. Keisai Biotech (Taicang) Co., Ltd., and Suzhou Hai Miao Biotechnology Co., Ltd. have joined the center.

China Bio news release, October 10, 2016

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny